文献速递肾移植

肾移植后5年肾小球体积、硬化与缺血的变化:发生率及与晚期移植物衰竭的相关性

Changes in Glomerular Volume, Sclerosis, and Ischemia at 5 Years after Kidney Transplantation: Incidence and Correlation with Late Graft Failure.
PubMed 文献 · J Am Soc Nephrol · 2022-11-17

该研究对835例肾移植受者的监测性活检(植入时及移植后1年、5年)进行数字扫描形态计量,量化肾小球体积、全球硬化肾小球百分比(GSG)和缺血表现肾小球百分比,并用Cox模型评估其与移植物衰竭的关系。结果显示三项指标从植入至5年均增加,5年时GSG和缺血肾小球百分比升高预测移植物丢失,仅缺血肾小球百分比在调整Banff评分后仍独立预测5年移植物衰竭。

要点

  • 从植入至5年,平均肾小球体积从2.8×10^6增至3.6×10^6 µm^3,GSG从3.2%升至13.2%,缺血肾小球从0.8%升至9.5%。
  • 5年时仅5.3%活检有≥40%缺血肾小球,但其中45%移植物衰竭,而<40%缺血肾小球者仅11.6%衰竭。
  • 5年时仅缺血肾小球百分比在调整所有Banff评分后仍独立预测移植物衰竭。

核心结论

  • 肾小球改变反映预测移植物丢失的重要病理过程,在监测性活检上定量测量肾小球改变(尤其缺血表现肾小球比例)可能增强现行Banff系统,并作为临床干预试验的有用替代终点。

研究设计与样本

  • 研究纳入835例肾移植受者,对植入时及移植后1年、5年的监测性活检数字扫描进行形态计量,量化肾小球体积及GSG和缺血表现肾小球百分比,并用Cox比例风险模型评估移植物衰竭风险。

主要发现

  • 从植入至5年,平均肾小球体积增加近30%(从2.8×10^6增至3.6×10^6 µm^3),平均GSG百分比从3.2%升至13.2%,平均缺血表现肾小球百分比从0.8%升至9.5%。
  • 5年活检时较高的GSG百分比和缺血表现肾小球百分比预测移植物丢失。
  • 5年活检时三项肾小球特征相关:GSG百分比与缺血肾小球百分比正相关,二者均与肾小球体积负相关。
  • 5年时仅5.3%活检有≥40%缺血肾小球,但其中45%移植物衰竭,而<40%缺血肾小球者为11.6%。
  • Banff评分越高,GSG和缺血百分比越高越常见,但5年时仅缺血肾小球百分比在调整Banff评分的预测模型中仍有额外预测价值。

临床怎么用

  • 作者认为,在监测性活检上定量测量肾小球改变(尤其缺血表现肾小球比例)可能增强现行Banff系统,并作为临床干预试验的有用替代终点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SIGNIFICANCE STATEMENT: Glomerular volume, ischemic glomeruli, and global glomerulosclerosis are not consistently assessed on kidney transplant biopsies. The authors evaluated morphometric measures of glomerular volume, the percentage of global glomerulosclerosis, and the percentage of ischemic glomeruli and assessed changes in these measures over time to determine whether such changes predict late allograft failure. All three features increased from transplant to five-year biopsy. Kidneys with smaller glomeruli at 5 years had more global glomerulosclerosis and a higher percentage of ischemic-appearing glomeruli. Smaller glomeruli and increasing percentages of global glomerulosclerosis and ischemic glomeruli at 5 years predicted allograft failure. Only increased percentage of ischemic glomeruli predicted allograft failure at 5 years independent of all Banff scores. Glomerular changes reflect pathologic processes that predicted allograft loss; measuring them quantitatively might enhance the current Banff system and provide biomarkers for intervention trials. BACKGROUND: Histology can provide insight into the biology of renal allograft loss. However, studies are lacking that use quantitative morphometry to simultaneously assess changes in mean glomerular volume and in the percentages of globally sclerosed glomeruli (GSG) and ischemic-appearing glomeruli in surveillance biopsies over time to determine whether such changes are correlated with late graft failure. METHODS: We used digital scans of surveillance biopsies (at implantation and at 1 and 5 years after transplantation) to morphometrically quantify glomerular volume and the percentages of GSG and ischemic-appearing glomeruli in a cohort of 835 kidney transplants. Cox proportional hazards models assessed the risk of allograft failure with these three glomerular features. RESULTS: From implantation to 5 years, mean glomerular volume increased by nearly 30% (from 2.8×10 6 to 3.6×10 6 µm 3 ), mean percentage of GSG increased from 3.2% to 13.2%, and mean percentage of ischemic-appearing glomeruli increased from 0.8% to 9.5%. Higher percentages of GSG and ischemic-appearing glomeruli at 5-year biopsy predicted allograft loss. The three glomerular features at 5-year biopsy were related; the percentage of GSG and the percentage of ischemic glomeruli were positively correlated, and both were inversely correlated to glomerular volume. At 5 years, only 5.3% of biopsies had ≥40% ischemic glomeruli, but 45% of these grafts failed (versus 11.6% for <40% ischemic glomeruli). Higher Banff scores were more common with increasing percentages of GSG and ischemia, but at 5 years, only the percentage of ischemic glomeruli added to predictive models adjusted for Banff scores. CONCLUSIONS: Glomerular changes reflect important pathologic processes that predict graft loss. Measuring glomerular changes quantitatively on surveillance biopsies, especially the proportion of ischemic-appearing glomeruli, may enhance the current Banff system and be a useful surrogate end point for clinical intervention trials. PODCAST: This article contains a podcast at.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Denic A, Bogojevic M, Subramani R, et al. Changes in Glomerular Volume, Sclerosis, and Ischemia at 5 Years after Kidney Transplantation: Incidence and Correlation with Late Graft Failure. J Am Soc Nephrol. 2022. PMID: 36396330. doi:10.1681/ASN.2022040418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。